Table of contents
Table of Contents
1 Industry Overview
 1.1 Definition and Specifications of Insomnia Drug
    1.1.1 Definition of Insomnia Drug
    1.1.2 Specifications of Insomnia Drug
 1.2 Classification of Insomnia Drug
    1.2.1 Tablets
    1.2.2 Capsules
    1.2.3 Mist formulation
 1.3 Applications of Insomnia Drug
 1.4 Industry Chain Structure of Insomnia Drug
 1.5 Industry Overview of Insomnia Drug
 1.6 Industry Policy Analysis of Insomnia Drug
 1.7 Industry News Analysis of Insomnia Drug2 Manufacturing Cost Structure Analysis of Insomnia Drug
 2.1 Bill of Materials (BOM) of Insomnia Drug
 2.2 BOM Price Analysis of Insomnia Drug
 2.3 Labor Cost Analysis of Insomnia Drug
 2.4 Depreciation Cost Analysis of Insomnia Drug
 2.5 Manufacturing Cost Structure Analysis of Insomnia Drug
 2.6 Manufacturing Process Analysis of Insomnia Drug
 2.7 United States Price, Cost and Gross of Insomnia Drug 2011-20163 Technical Data and Manufacturing Plants Analysis
 3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
 3.2 Manufacturing Plants Distribution of United States Key Insomnia Drug Manufacturers in 2015
 3.3 R&D Status and Technology Source of United States Insomnia Drug Key Manufacturers in 2015
 3.4 Raw Materials Sources Analysis of United States Insomnia Drug Key Manufacturers in 20154 Production Analysis of Insomnia Drug by Regions, Type, and Applications
 4.1 United States Production of Insomnia Drug by Regions 2011-2016
 4.2 United States Production of Insomnia Drug by Type 2011-2016
 4.3 United States Sales of Insomnia Drug by Applications 2011-2016
 4.4 Price Analysis of United States Insomnia Drug Key Manufacturers in 2015
 4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Insomnia Drug 2011-20165 Consumption Volume and Consumption Value Analysis of Insomnia Drug by Regions
 5.1 United States Consumption Volume of Insomnia Drug by Regions 2011-2016
 5.2 United States Consumption Value of Insomnia Drug by Regions 2011-2016
 5.3 United States Consumption Price Analysis of Insomnia Drug by Regions 2011-20166 Analysis of Insomnia Drug Production, Supply, Sales and Market Status 2011-2016
 6.1 Capacity, Production, Sales, and Revenue of Insomnia Drug 2011-2016
 6.2 Production Market Share and Sales Market Share Analysis of Insomnia Drug 2014-2015
 6.3 Sales Overview of Insomnia Drug 2011-2016
 6.4 Supply, Consumption and Gap of Insomnia Drug 2011-2016
 6.5 Import, Export and Consumption of Insomnia Drug 2011-2016
 6.6 Cost, Price, Revenue and Gross Margin of Insomnia Drug 2011-20167 Analysis of Insomnia Drug Industry Key Manufacturers
 7.1 Eisai
    7.1.1 Company Profile
    7.1.2 Product Picture and Specifications
        7.1.2.1 Type I
        7.1.2.2 Type II
        7.1.2.3 Type III
    7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.1.4 Contact Information 7.2 Merck
    7.2.1 Company Profile
    7.2.2 Product Picture and Specifications
        7.2.2.1 Type I
        7.2.2.2 Type II
        7.2.2.3 Type III
    7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.2.4 Contact Information
 7.3 Pfizer
    7.3.1 Company Profile
    7.3.2 Product Picture and Specifications
        7.3.2.1 Type I
        7.3.2.2 Type II
        7.3.2.3 Type III
    7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.3.4 Contact Information
 7.4 Sanofi
    7.4.1 Company Profile
    7.4.2 Product Picture and Specifications
        7.4.2.1 Type I
        7.4.2.2 Type II
        7.4.2.3 Type III
    7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.4.4 Contact Information
 7.5 Takeda
    7.5.1 Company Profile
    7.5.2 Product Picture and Specifications
        7.5.2.1 Type I
        7.5.2.2 Type II
        7.5.2.3 Type III
    7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.5.4 Contact Information
 7.6 Astellas
    7.6.1 Company Profile
    7.6.2 Product Picture and Specifications
        7.6.2.1 Type I
        7.6.2.2 Type II
        7.6.2.3 Type III
    7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.6.4 Contact Information
 7.7 Biocodex
    7.7.1 Company Profile
    7.7.2 Product Picture and Specifications
        7.7.2.1 Type I
        7.7.2.2 Type II
        7.7.2.3 Type III
    7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.7.4 Contact Information
 7.8 Dainippon Sumitomo
    7.8.1 Company Profile
    7.8.2 Product Picture and Specifications
        7.8.2.1 Type I
        7.8.2.2 Type II
        7.8.2.3 Type III
    7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.8.4 Contact Information
 7.9 ECR Pharmaceuticals (Valeant)
    7.9.1 Company Profile
    7.9.2 Product Picture and Specifications
        7.9.2.1 Type I
        7.9.2.2 Type II
        7.9.2.3 Type III
    7.9.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.9.4 Contact Information
 7.10 Fidia Farmaceutici
    7.10.1 Company Profile
    7.10.2 Product Picture and Specifications
        7.10.2.1 Type I
        7.10.2.2 Type II
        7.10.2.3 Type III
    7.10.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.10.4 Contact Information
 7.11 Flynn Pharma
    7.11.1 Company Profile
    7.11.2 Product Picture and Specifications
        7.11.2.1 Type I
        7.11.2.2 Type II
        7.11.2.3 Type III
    7.11.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.11.4 Contact Information
 7.12 Johnson & Johnson
    7.12.1 Company Profile
    7.12.2 Product Picture and Specifications
        7.12.2.1 Type I
        7.12.2.2 Type II
        7.12.2.3 Type III
    7.12.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.12.4 Contact Information
 7.13 Juste
    7.13.1 Company Profile
    7.13.2 Product Picture and Specifications
        7.13.2.1 Type I
        7.13.2.2 Type II
        7.13.2.3 Type III
    7.13.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.13.4 Contact Information
 7.14 Meda
    7.14.1 Company Profile
    7.14.2 Product Picture and Specifications
        7.14.2.1 Type I
        7.14.2.2 Type II
        7.14.2.3 Type III
    7.14.3 Capacity, Production, Price, Cost, Gross and Revenue
    7.14.4 Contact Information
8 Price and Gross Margin Analysis
 8.1 Analysis of Price
 8.2 Gross Margin Analysis
 8.3 Price Comparison by Regions
 8.4 Price Analysis of Different Insomnia Drug Product Types
 8.5 Market Share Analysis of Different Insomnia Drug Price Levels
 8.6 Gross Margin Analysis of Different Insomnia Drug Applications9 Marketing Trader or Distributor Analysis of Insomnia Drug
 9.1 Marketing Channels Status of Insomnia Drug
 9.2 Traders or Distributors of Insomnia Drug with Contact Information
 9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Insomnia Drug
 9.4 United States Import, Export and Trade Analysis of Insomnia Drug10 Development Trend of Insomnia Drug Industry 2016-2021
 10.1 Capacity and Production Overview of Insomnia Drug 2016-2021
 10.2 Production Market Share by Product Types of Insomnia Drug 2016-2021
 10.3 Sales and Sales Revenue Overview of Insomnia Drug 2016-2021
 10.4 United States Sales of Insomnia Drug by Applications 2016-2021
 10.5 Import, Export and Consumption of Insomnia Drug 2016-2021
 10.6 Cost, Price, Revenue and Gross Margin of Insomnia Drug 2016-202111 Industry Chain Suppliers of Insomnia Drug with Contact Information
 11.1 Major Raw Materials Suppliers of Insomnia Drug with Contact Information
 11.2 Manufacturing Equipment Suppliers of Insomnia Drug with Contact Information
 11.3 Major Players of Insomnia Drug with Contact Information
 11.4 Key Consumers of Insomnia Drug with Contact Information
 11.5 Supply Chain Relationship Analysis of Insomnia Drug12 New Project Investment Feasibility Analysis of Insomnia Drug
 12.1 New Project SWOT Analysis of Insomnia Drug
 12.2 New Project Investment Feasibility Analysis of Insomnia Drug13 Conclusion of the United States Insomnia Drug Industry 2016 Market Research Report